跳至主要内容

A New Tool for Identifying Active Metabolites in Biological Systems

Active metabolomics is swiftly becoming a revolutionary tool in the realm of scientific research, providing us an in-depth perspective to the world of active metabolites in biological systems. Through its multi-disciplinary approach, active metabolomics, with a foundation in biochemistry, molecular biology, and computational biology, offers insights into the intricate networks of metabolites at play within biological organisms.

Active metabolites form the functional backbone within biological systems. They range from basic building blocks such as glucose and amino acids to signaling molecules such as hormones, neurotransmitters, and other biologically active entities. The identification and understanding of these metabolites are paramount for a comprehensive understanding of physiological functions in living organisms and unraveling complex biological processes.

Active metabolomics provides us with a breakthrough, allowing a systematic approach to studying active metabolites within organisms. From sampling to sample preparation, purification, qualitative and quantitative analysis using methodologies such as mass spectrometry or nuclear magnetic resonance (NMR), followed by data processing and bioinformatics analysis, active metabolomics enables a holistic understanding of metabolites and their intricate interplays.

In practice, active metabolomics requires the extraction and separation of metabolites from biological samples, followed by an analytical process using methods such as mass spectrometry, gas chromatography, or liquid chromatography. The generated data is then interpreted using computer-assisted data processing techniques, allowing for the identification of specific active metabolites, understanding their molecular structures, and exploring their metabolic pathways and mechanistic roles within biological systems.


In conclusion, the advent of active metabolomics not only helps elucidate the complex happenings within biological systems but also provides us with new perspectives and tools for the study of complex life phenomena. The deployment of this technique will undoubtedly furnish us with abundant and powerful means to delve into basic life science questions and addresses practical issues in medical health in the future.

The MetID team of Medicilon is composed of experienced scientists. We provide fast and reliable in vivo and in vitro MetID and reactive metabolite capture services. We also support new drug screening and domestic and oversees IND filings. Since the establishment of MetID team, Medicilon has successfully completed multiple different types of research projects for clients, including challenging peptide MetID research.

评论

此博客中的热门博文

Medicilon and Binhui Biopharmaceutical Have Reached a Strategic Collaboration to Jointly Draw a New Blueprint for the Development of New Biological Drugs

  On March 18, Medicilon and Binhui Biopharmaceutical (Binui Bio) announced a strategic collaboration.  The two parties will work together to jointly explore the possibilities in cutting-edge fields such as oncolytic viruses, nucleic acid drugs and protein drugs. Gather and Work Together to Create Advantages      Facilitate the Research and Development of Oncolytic Viruses, Nucleic Acids, Proteins and Other Drugs As a one-stop biopharmaceutical comprehensive preclinical R&D service CRO, Medicilon has been developing and accumulating for 20 years, always adhering to the spirit of innovation, and has successfully constructed bi/multi-specific antibodies,  ADCs ,  mRNA vaccines ,  small nucleic acid drugs ,  PROTAC , and  CGT technical service platform  that have helped 421 INDs obtain clinical approval.  It is this outstanding achievement that has earned Medicilon wide recognition in the industry and laid a solid foundation f...

A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp3-Sp2 Bond Formation

  In 2012, a nickel-catalyzed reductive alkylation method of aryl bromides and chlorides was reported. Under the optimized conditions, a variety of aryl and vinyl bromides as well as active aryl chloride can be reductively coupled with alkyl bromides in high yields. The protocols were highly functional-group tolerant and the reactions were not air or moisture sensitive. The reaction showed different chemoselectivity than conventional cross-coupling reactions. Substrates bearing both anelectrophilic and nucleophilic carbon resulted in selective coupling at the electrophilic carbon (R-X) and no reaction occurred at the nucleophilic carbon (R-[M]). The 2010 Nobel Prize in Chemistry was awarded for the Pd-catalyzed cross-coupling, and in the past decade the progress in cross-coupling has not only had a significant impact on academic research but has also influenced the industrial synthetic application. The transition-metal-catalyzed union of nucleophilic organo-boronic acids with elect...

What is Toxicokinetics?

Toxicokinetics  is essentially the study of “how a substance gets into the body and what happens to it in the body”. Four processes are involved in toxicokinetics. The study of the kinetics (movement) of chemicals was originally conducted with pharmaceuticals and thus the term pharmacokinetics became commonly used. In addition, toxicology studies were initially conducted with drugs. However, the science of toxicology has evolved to include environmental and occupational chemicals as well as drugs. Toxicokinetics is thus the appropriate term for the study of the kinetics of all toxic substances. Frequently the terms  toxicokinetics ,  pharmacokinetics , or disposition may be found in the literature to have the same meaning. Disposition is often used in place of toxicokinetics to describe the time-course of movement of chemicals through the body (that is, how does the body dispose of a xenobiotic?). The disposition of a toxicant along with its’ biological reactivi...